Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,136,434Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Velcade

02 7Velcade

PharmaCompass

01

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Velcade

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bortezomib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 408

2019 Revenue in Millions : 751

Growth (%) : -46

blank

02

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Velcade

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bortezomib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 1,100

2018 Revenue in Millions : 1,206

Growth (%) : -9

blank

03

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Velcade

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bortezomib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 981

2019 Revenue in Millions : 1,123

Growth (%) : -13

blank

04

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

05

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Velcade

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bortezomib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 388

2021 Revenue in Millions : 925

Growth (%) : -58

blank

06

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Velcade

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bortezomib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 48

2022 Revenue in Millions : 388

Growth (%) : -86

blank

07

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Velcade

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bortezomib

Main Therapeutic Indication : Oncology

Currency : USD

2014 Revenue in Millions : -2.50%

2013 Revenue in Millions :

Growth (%) :

blank

08

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Velcade

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bortezomib

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 1,618

2014 Revenue in Millions : 1,333

Growth (%) : -18%

blank

09

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Velcade

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bortezomib

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 1,224

2015 Revenue in Millions : 1,333

Growth (%) : -8

blank

10

Brand Name : Velcade

Bortezomib

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Velcade

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bortezomib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 1,114

2016 Revenue in Millions : 1,224

Growth (%) : -9

blank